The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence

The burden and cost of heart failure management, primarily in the form of hospitalization in the setting of decompensated heart failure, continue to be some of the biggest clinical challenges in cardiovascular medicine. In recently published randomized controlled trials, including DAPA-HF, sodium-gl...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Manasvi, Rao, Shiavax, Manek, Gaurav, Fonarow, Gregg C, Ghosh, Raktim K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367215/
https://www.ncbi.nlm.nih.gov/pubmed/34408424
http://dx.doi.org/10.2147/TCRM.S275076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367215/
https://www.ncbi.nlm.nih.gov/pubmed/34408424
http://dx.doi.org/10.2147/TCRM.S275076

Ejemplares similares